Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Durect Corp. (DRRX), Cupertino, Calif. Product: Duros sufentanil Business: Neurological
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury